CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P3
Near historical low
vs 2Y Ago
-1.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -14.65% |
| Q3 2025 | -9.54% |
| Q2 2025 | 1.94% |
| Q1 2025 | 1.50% |
| Q4 2024 | 3.03% |
| Q3 2024 | 3.33% |
| Q2 2024 | -3.60% |
| Q1 2024 | -8.64% |
| Q4 2023 | 8.58% |
| Q3 2023 | 68.08% |
| Q2 2023 | 9.52% |
| Q1 2023 | -2.65% |
| Q4 2022 | -18.91% |
| Q3 2022 | -3.47% |
| Q2 2022 | 6.12% |
| Q1 2022 | -8.12% |
| Q4 2021 | -7.12% |
| Q3 2021 | 11.37% |
| Q2 2021 | 0.78% |
| Q1 2021 | 1.52% |
| Q4 2020 | -2.95% |
| Q3 2020 | 10.52% |
| Q2 2020 | -8.13% |
| Q1 2020 | -11.08% |
| Q4 2019 | -2.30% |
| Q3 2019 | 15.07% |
| Q2 2019 | 9.67% |
| Q1 2019 | -12.51% |
| Q4 2018 | -5.55% |
| Q3 2018 | 15.12% |
| Q2 2018 | -4.44% |
| Q1 2018 | 9.72% |
| Q4 2017 | -6.38% |
| Q3 2017 | 15.31% |
| Q2 2017 | 23.25% |
| Q1 2017 | -10.67% |
| Q4 2016 | -9.99% |
| Q3 2016 | -3.38% |
| Q2 2016 | 18.92% |
| Q1 2016 | 0.02% |